Page 7 - Indus Tower News Today

The major concern that analysts point out is if the high rate of tenancy addition is unlikely to sustain as Bharti Airtel is close to completing its rural 4G rollout and 5G rollout over the next 12 months will largely come as loading.

A potential fundraise from Vodafone Idea (Vi) would improve Indus Towers chances of recovering its massive old dues – now pegged at Rs 9,500 crore -- from its cash-strapped telco customer, said analysts. They said that with a likely promoter equity infusion (Rs 2,000 crore) and possible relief from lenders, Vis survival is likely, at least until 2HFY26.

It added that with a likely promoter equity infusion (Rs 2,000 crore) and possible relief from lenders, Vis survival is likely, at least until 2HFY26.

Vodafone Idea: It added that with a likely promoter equity infusion (Rs 2,000 crore) and possible relief from lenders, Vi’s survival is likely, at least until 2HFY26.

Bank of Baroda formed a Bullish Harami pattern on the daily chart. It found support at the 21-day EMA, indicating potential buying interest.

Adani Transmission and Adani Total Gas stocks slumped by over 3-4% after being removed from the MSCI Global Standard Index, resulting in a combined loss of $356 million.

Singapore dominant telecom operator Singtel last week announced that net profit for the financial year which ended March 2023 was up 14 per cent to SGD 2.23 b

Group revenue was lower by 4.7 per cent, coming in at SGD 14.6 billion (USD 10.8 billion) mainly due to the absence of revenue from the digital advertising subsidiary Amobee which was sold in July 2022, , Singtel Group

The agency has outsourced the work of installing small and microcell telecom towers on 1,500 pillars located along the 35-km-long combined stretch of Metro 2A and Metro 7.

According to Nuvama Institutional Equities, there are chances that stocks such as Jindal Steel and Power (JSPL), IDBI Bank, Punjab National Bank, Canara Bank, TVS Motor, Tube Investment, Zydus Lifesciences and newly-listed firm Mankind Pharma may enter into the largecap category.